New injectable antiretroviral treatment for HIV patients
A phase II clinical trial has paved the way to the implantation of all-injectable antiretroviral therapies with a lower frequency of administration...
List view / Grid view
News
Tecan launches new range of clear disposable tips
Tecan has introduced a selection of clear Liquid Handling (LiHa) disposable tips*, creating a one-stop shop for all your disposable tip needs...
New gasket and braided hose range from BioPure sets the new standard for confident fluid path validation
Important product additions to the BioPure range from Watson-Marlow Fluid Technology Group will reinforce the organisation’s position as the leading provider of technologies for complete high purity fluid path solutions...
Artificial intelligence for human age-reversal
Insilico Medicine develops the advanced artificial intelligence algorithms to study the ageing processes and discover new interventions in ageing...
FDA approves new targeted treatment for acute myeloid leukemia
The U.S. Food and Drug Administration has granted the approval of Idhifa to Celgene Corporation and RealTime IDH2 Assay to Abbott Laboratories...
AdvantaPure® announces its ISO 9001:2015 Certification
Validates the Company’s Quality Management System...
New imaging technique allows early assessment of aortic aneurysm
Researchers have developed a new imaging technique which allows early assessment of aortic aneurysm which could potentially be used to assess a patient's rupture risk for abdominal aortic aneurysm...
New drug may slow progression of Parkinson’s disease
A preclinical model of Parkinson's disease was employed to compare the effects of the dopamine agonist ropinirole to a new drug...
Rainin’s calibration service helps ensure accurate, precise pipetting
Scientists at Novartis in Jersey, USA, rely on METTLER TOLEDO Rainin’s calibration and maintenance service to guarantee the correct operation of their pipettes...
FDA grants Breakthrough Therapy Designation status for acalabrutinib
It has been announced that the FDA has awarded AstraZeneca’s acalabrutinib product for MCL treatment Breakthrough Therapy Designation...
PEG-IONCs show potential as next-generation MRI contrast agents
A research team formed have tested a new non-toxic contrast agent for magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA) that could be superior to the current dye, gadolinium.
Consortium established to support ICH M7 compliance
An industry work-group comprising of toxicologists, pharmaceutical companies and data experts plans to unveil the early results of a data sharing project...
Imfinzi wins breakthrough therapy designation
AstraZeneca and MedImmune, have today announced that the US Food and Drug Administration has granted breakthrough therapy designation for Imfinzi for the treatment of patients with locally-advanced, unresectable non-small cell lung cancer...
UK Biobank releases genetic data on 0.5m people
Genetic data on half a million people was made available for research last week by the UK Biobank study. Information about participants’ health and well-being, key body measurements, their diet, occupational history, mental health and activity levels are also included...
The return of the FT Global Pharmaceutical and Biotechnology Conference
The FT Global Pharmaceutical and Biotechnology Conference, now in its 35th successful year, will be returning to London this November...
